Pretreatment lactate dehydrogenase may predict outcome of advanced non small‐cell lung cancer patients treated with immune checkpoint inhibitors: A meta‐analysis

The main aim of this study is to investigate whether baseline lactate dehydrogenase (LDH) is associated with the clinical outcome of non small‐cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (ICIs). We searched Pubmed, the Cochrane Central library and Embase for periphera...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhibo, Li, Ye, Yan, Xiang, Song, Qi, Wang, Guoqiang, Hu, Yi, Jiao, Shunchang, Wang, Jinliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488146/
https://www.ncbi.nlm.nih.gov/pubmed/30848091
http://dx.doi.org/10.1002/cam4.2024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488146/
https://www.ncbi.nlm.nih.gov/pubmed/30848091
http://dx.doi.org/10.1002/cam4.2024

Ejemplares similares